Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 577–600 of 1,485 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: HCC, Hepatocellular Carcinoma, Liver Cancer, Hepatic Neoplasm, Primary Liver Cancer, Liver Neoplasm
Interventions: Lumason, Sonazoid; Diagnostic Test
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lifestyle
Interventions: Yoga, Cognitive Behavioral Therapy, Music; Behavioral
Lead sponsor: Imad Najm MD; Other
Eligibility: 18 Years to 75 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Knee Arthroplasty, Total
Interventions: ultrasound guided injection of local anesthetic between the popliteal artery and the capsule of the knee (iPACK); Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Crohn's Disease, IBD
Interventions: Infliximab, Adalimumab; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Year to 22 Years
Enrollment: 239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Hartford, Connecticut • Cincinnati, Ohio • Columbus, Ohio + 1 more

Conditions: Prostate Cancer
Interventions: 123I-MIP-1072; Drug
Lead sponsor: Molecular Insight Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Feeding Disorders, Feeding and Eating Disorders, Avoidant/Restrictive Food Intake Disorder
Interventions: Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care, Intensive Multidisciplinary Feeding Intervention (IMFI) standard of care + rapid tube weaning; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Months to 6 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Melanoma, Ovarian Cancer, Sarcoma, Bone, CNS-Spinal CD/MEMBR, NOS, Lymph Nodes, Soft Tissue
Interventions: IGIMRT using a single dose of 24 Gy, IGIMRT 27 Gy in 3 fractions; Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 2
States / cities: San Francisco, California • New York, New York

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: Lubiprostone, Polyethylene glycol with electrolytes; Drug · Other
Lead sponsor: Augusta University; Other
Eligibility: 50 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Total Knee Arthroplasty
Interventions: 3D-Printed Mechanical Balancer; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hearing Loss
Interventions: Distortion product otoacoustic emissions (DPOAE); Diagnostic Test
Lead sponsor: Gateway Biotechnology, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Metastatic Breast Cancer, Lobular Breast Carcinoma
Interventions: Blood Specimen; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2036
U.S. locations: 4
States / cities: San Diego, California • San Francisco, California • Philadelphia, Pennsylvania + 1 more

Conditions: Newly Diagnosed Multiple Myeloma, Multiple Myeloma, Autologous Stem Cell Transplantation
Interventions: Daratumumab, Lenalidomide, Bortezomib, Dexamethasone; Biological · Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Carcinoma, Renal Cell
Interventions: Sunitinib; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Pelvic Pain Syndrome
Interventions: Chronic Pelvic Pain Treatment Guide; Behavioral
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Telemetry, Patient Monitoring
Interventions: Vital Sync IM & VPMP (Surveillance Monitoring), Telemetry Monitoring; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Neurocognitive Disorders, Cognitive Dysfunction, Traumatic Brain Injury, Multiple Sclerosis, Mild Cognitive Impairment
Interventions: CRT, CBT, Modifiable lifestyle factors, Usual care Psychoeducation; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Class I Obesity, Pediatric Obesity
Interventions: Virtual Housecalls; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 12 Years to 15 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Henrico, Virginia

Conditions: Moderate to Severe Psoriatic Arthritis
Interventions: DDY391, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 8
States / cities: Huntington Beach, California • Duncansville, Pennsylvania • Philadelphia, Pennsylvania + 5 more

Conditions: Influenza, Respiratory Tract Infections
Interventions: Enhanced texts with Callback by a Person, Enhanced Bidirectional Texts; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 6 Months and older
Enrollment: 246,295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Leukemia, Aplastic Anemia, Bone Marrow Failure Syndromes, SCID
Interventions: PCA plus methadone (Experimental), PCA Alone (SOC); Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 6 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Post Operative, Post Operative Analgesia, Urogynecologic Surgery
Interventions: Tizanidine, Standard-of-Care Therapy; Drug · Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Diffuse Large B-Cell Lymphoma
Interventions: Bridging Radiation Therapy; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal, Neonatal Opioid Withdrawal Syndrome
Interventions: Morphine PRN, Morphine scheduled; Drug
Lead sponsor: Indiana University; Other
Eligibility: Up to 28 Days
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Individuals Who Use Violence, Interpersonal Violence
Interventions: Program For Alleviating Relationship Trauma and Stress through New Behaviors, DVIT Treatment As Usual (TAU); Behavioral
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years and older · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Malden, Massachusetts • Tumwater, Washington

Search by objective public record fields.

Y-90 Treatment Response Using Transarterial Radioembolization

Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy

The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)

Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)

A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

Evaluating Hunger Manipulation During Feeding Intervention

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Efficacy of Lubiprostone in Combination With Standard PEG Preparation

Utilization of a 3D Printed Mechanical Balancer During Total Knee Arthroplasty (TKA)

Hearing Changes After Surgery

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing

Outcomes of a Multidisciplinary Program for the Treatment of Chronic Pelvic Pain

Surveillance Monitoring as an Alternative to Telemetry

A Pilot Randomized Controlled Trial: CoINTEGRATE

Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)

Methadone as an Alternative Treatment for Children Underdoing HSCT

Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study

Hyperfractionated Dual Equivalent Fractionated Radiation Therapy

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Program for Alleviating Relationship Trauma and Stress for Intimate Partner Violence - Randomized Control Trial